Key result
The Padua ESH 2011 Satellite Symposium highlighted that the modest use of combination therapy is the major reason for uncontrolled hypertension and discussed new therapeutic tools.
Highlights from the ESH 2011 Satellite Symposium emphasize the underutilization of combination therapy as a primary driver of uncontrolled hypertension.
May support greater combination therapy use; leaves open validation of new tools in uncontrolled hypertension.
The Padua ESH 2011 Satellite Symposium on uncontrolled hypertension was focused on why only a relatively small percentage of patients under treatment do not reach 'safe' blood pressure levels; the major reason being the modest use of combination therapy. It was also an occasion to discuss new pharmacological and nonpharmacological tools, some of which appear to be efficacious when even the 'appropriate' traditional therapeutic strategy fails to work.
No takes yet. Share an insight, caveat, or question.
Pessina et al. (2011) conducted a review in Uncontrolled hypertension. Combination therapy and new pharmacological/nonpharmacological tools was evaluated. The Padua ESH 2011 Satellite Symposium highlighted that the modest use of combination therapy is the major reason for uncontrolled hypertension and discussed new therapeutic tools.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: